Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4,705 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 123,950 | 118,255 |
| Total Cites | 10,862 | 12,920 |
| H-index | 51 | 55 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 9 | 13 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 1,142 | 1,322 |
| Number of Single+First+Last Authored Papers | 125 | 125 |
| Total Cites to Single+First+Last Authored Papers | 4,867 | 5,391 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9,562 | 11,148 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.16 |
| Self-Citation Percentage |
15.93%
|
|
Schneider-Stock, Regine
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Germany
2024 Rank: 119,754
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4,607 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 119,754 | 113,600 |
| Total Cites | 10,272 | 12,318 |
| H-index | 50 | 53 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 9 | 13 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 1,092 | 1,273 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 4,577 | 5,088 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9,012 | 10,595 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.16 |
| Self-Citation Percentage |
16.61%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4,649 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 119,888 | 113,300 |
| Total Cites | 9,692 | 11,709 |
| H-index | 47 | 50 |
| Hm-index | 17 | 19 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 8 | 12 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 1,076 | 1,256 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 4,315 | 4,802 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,481 | 10,050 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
17.23%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4,669 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 120,945 | 114,175 |
| Total Cites | 8,805 | 10,719 |
| H-index | 45 | 48 |
| Hm-index | 16 | 18 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 8 | 12 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 917 | 1,067 |
| Number of Single+First+Last Authored Papers | 109 | 109 |
| Total Cites to Single+First+Last Authored Papers | 3,853 | 4,290 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,726 | 9,242 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.16 |
| Self-Citation Percentage |
17.86%
|
|
Schneider-Stock, Regine
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Germany
2021 Rank: 128,442
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4,951 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 128,442 | 116,563 |
| Total Cites | 8,447 | 10,312 |
| H-index | 43 | 46 |
| Hm-index | 15 | 17 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 6 | 10 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 877 | 1,024 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 3,670 | 4,094 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,424 | 8,896 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.16 |
| Self-Citation Percentage |
18.09%
|
|
Schneider-Stock, Regine
Universitätsklinik Erlangen und Medizinische Fakultät,
Germany
2020 Rank: 123,200
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4,948 out of 230,678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 123,200 | 112,329 |
| Total Cites | 7,691 | 9,481 |
| H-index | 42 | 45 |
| Hm-index | 15 | 17 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 5 | 9 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 834 | 979 |
| Number of Single+First+Last Authored Papers | 107 | 107 |
| Total Cites to Single+First+Last Authored Papers | 3,291 | 3,697 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,728 | 8,146 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.16 |
| Self-Citation Percentage |
18.88%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.